Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease

Mov Disord. 2007 Oct 15;22(13):1985. doi: 10.1002/mds.21582.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol / blood*
  • Cholesterol, LDL / blood*
  • Coenzymes / blood
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Parkinson Disease / blood*
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Factors
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / blood

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Coenzymes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Ubiquinone
  • Cholesterol
  • coenzyme Q10